Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Preferred Stock Liabilities: 2013-2016

Historic Preferred Stock Liabilities for Soleno Therapeutics (SLNO) over the last 3 years, with Dec 2016 value amounting to $13.

  • Soleno Therapeutics' Preferred Stock Liabilities rose 160.00% to $13 in Q4 2016 from the same period last year, while for Dec 2016 it was $13, marking a year-over-year increase of 160.00%. This contributed to the annual value of $13 for FY2016, which is 160.00% up from last year.
  • As of FY2016, Soleno Therapeutics' Preferred Stock Liabilities stood at $13, which was up 160.00% from $5 recorded in FY2015.
  • In the past 5 years, Soleno Therapeutics' Preferred Stock Liabilities ranged from a high of $15.4 million in FY2013 and a low of $5 during FY2015.
  • Moreover, its 2-year median value for Preferred Stock Liabilities was $9 (2015), whereas its average is $9.
  • Data for Soleno Therapeutics' Preferred Stock Liabilities shows a peak YoY soared of 160.00% (in 2016) over the last 5 years.
  • Soleno Therapeutics' Preferred Stock Liabilities (Yearly) stood at $15.4 million in 2013, then reached $5 in 2015, then skyrocketed by 160.00% to $13 in 2016.